Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study.

Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P.

CMAJ. 2019 Mar 11;191(10):E274-E282. doi: 10.1503/cmaj.181372.

2.

Outcomes Following Macrolide Use in Kidney Transplant Recipients.

Jeong R, Quinn RR, Lentine KL, Lloyd A, Ravani P, Hemmelgarn B, Braam B, Garg AX, Wen K, Wong-Chan A, Gourishankar S, Lam NN.

Can J Kidney Health Dis. 2019 Feb 21;6:2054358119830706. doi: 10.1177/2054358119830706. eCollection 2019.

3.

Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System.

Tonelli M, Wiebe N, Manns BJ, Klarenbach SW, James MT, Ravani P, Pannu N, Himmelfarb J, Hemmelgarn BR.

JAMA Netw Open. 2018 Nov 2;1(7):e184852. doi: 10.1001/jamanetworkopen.2018.4852.

4.

Complications From Tunneled Hemodialysis Catheters: A Canadian Observational Cohort Study.

Poinen K, Quinn RR, Clarke A, Ravani P, Hiremath S, Miller LM, Blake PG, Oliver MJ.

Am J Kidney Dis. 2019 Apr;73(4):467-475. doi: 10.1053/j.ajkd.2018.10.014. Epub 2019 Jan 12.

PMID:
30642607
5.

Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation.

Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL.

Transplant Direct. 2018 Sep 6;4(10):e389. doi: 10.1097/TXD.0000000000000828. eCollection 2018 Oct.

6.

Trends in Biopsy-Based Diagnosis of Kidney Disease: A Population Study.

Cunningham A, Benediktsson H, Muruve DA, Hildebrand AM, Ravani P.

Can J Kidney Health Dis. 2018 Sep 20;5:2054358118799690. doi: 10.1177/2054358118799690. eCollection 2018.

7.

Outcomes of the First and Second Hemodialysis Fistula: A Cohort Study.

Kamar F, Quinn RR, Oliver MJ, Viecelli AK, Hiremath S, MacRae J, Miller L, Blake P, Moist L, Garg AX, Lam NN, Kabani R, Clarke A, Liu P, Gillespie B, Ravani P.

Am J Kidney Dis. 2019 Jan;73(1):62-71. doi: 10.1053/j.ajkd.2018.06.007. Epub 2018 Aug 16.

PMID:
30122545
8.

Survival among older adults with kidney failure is better in the first three years with chronic dialysis treatment than not.

Tam-Tham H, Quinn RR, Weaver RG, Zhang J, Ravani P, Liu P, Thomas C, King-Shier K, Fruetel K, James MT, Manns BJ, Tonelli M, Murtagh FEM, Hemmelgarn BR.

Kidney Int. 2018 Sep;94(3):582-588. doi: 10.1016/j.kint.2018.03.007. Epub 2018 May 24.

PMID:
29803405
9.

A population-based cohort study defines prognoses in severe chronic kidney disease.

Tonelli M, Wiebe N, James MT, Klarenbach SW, Manns BJ, Ravani P, Strippoli GFM, Hemmelgarn BR; Alberta Kidney Disease Network.

Kidney Int. 2018 May;93(5):1217-1226. doi: 10.1016/j.kint.2017.12.013. Epub 2018 Mar 7.

PMID:
29525394
10.

Association between Duration of Predialysis Care and Mortality after Dialysis Start.

Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S, Tonelli M, Ravani P.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):893-899. doi: 10.2215/CJN.11951017. Epub 2018 Mar 5.

PMID:
29507006
11.

Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome.

Bonanni A, Calatroni M, D'Alessandro M, Signa S, Bertelli E, Cioni M, Di Marco E, Biassoni R, Caridi G, Ingrasciotta G, Bertelli R, Di Donato A, Bruschi M, Canepa A, Piaggio G, Ravani P, Ghiggeri GM.

Br J Clin Pharmacol. 2018 Jun;84(6):1238-1249. doi: 10.1111/bcp.13548. Epub 2018 Mar 25.

PMID:
29436729
12.

Controversies in vascular access.

Papini A, Ravani P, Quinn RR.

Curr Opin Nephrol Hypertens. 2018 May;27(3):209-213. doi: 10.1097/MNH.0000000000000403. Review.

PMID:
29406363
13.

Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.

Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):429-435. doi: 10.2215/CJN.08510817. Epub 2018 Jan 15.

14.

Risk, Predictors, and Outcomes of Acute Kidney Injury in Patients Admitted to Intensive Care Units in Egypt.

Abd ElHafeez S, Tripepi G, Quinn R, Naga Y, Abdelmonem S, AbdelHady M, Liu P, James M, Zoccali C, Ravani P.

Sci Rep. 2017 Dec 7;7(1):17163. doi: 10.1038/s41598-017-17264-7.

15.

Comparison of Patient Survival Between Hemodialysis and Peritoneal Dialysis Among Patients Eligible for Both Modalities.

Wong B, Ravani P, Oliver MJ, Holroyd-Leduc J, Venturato L, Garg AX, Quinn RR.

Am J Kidney Dis. 2018 Mar;71(3):344-351. doi: 10.1053/j.ajkd.2017.08.028. Epub 2017 Nov 22.

PMID:
29174322
16.

Derivation and External Validation of Prediction Models for Advanced Chronic Kidney Disease Following Acute Kidney Injury.

James MT, Pannu N, Hemmelgarn BR, Austin PC, Tan Z, McArthur E, Manns BJ, Tonelli M, Wald R, Quinn RR, Ravani P, Garg AX.

JAMA. 2017 Nov 14;318(18):1787-1797. doi: 10.1001/jama.2017.16326.

17.

Central venous catheters for chronic hemodialysis: Is "last choice" never the "right choice"?

Dumaine CS, Brown RS, MacRae JM, Oliver MJ, Ravani P, Quinn RR.

Semin Dial. 2018 Jan;31(1):3-10. doi: 10.1111/sdi.12655. Epub 2017 Nov 2. Review.

PMID:
29098715
18.

Randomized Crossover Trial of Blood Volume Monitoring-Guided Ultrafiltration Biofeedback to Reduce Intradialytic Hypotensive Episodes with Hemodialysis.

Leung KCW, Quinn RR, Ravani P, Duff H, MacRae JM.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1831-1840. doi: 10.2215/CJN.01030117. Epub 2017 Oct 10.

19.

Multi-Disciplinary Vascular Access Care and Access Outcomes in People Starting Hemodialysis Therapy.

Gill S, Quinn R, Oliver M, Kamar F, Kabani R, Devoe D, Mysore P, Pannu N, MacRae J, Manns B, Hemmelgarn B, James M, Tonelli M, Lewin A, Liu P, Ravani P.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1991-1999. doi: 10.2215/CJN.03430317. Epub 2017 Sep 14.

20.

The biobank for the molecular classification of kidney disease: research translation and precision medicine in nephrology.

Muruve DA, Mann MC, Chapman K, Wong JF, Ravani P, Page SA, Benediktsson H.

BMC Nephrol. 2017 Jul 26;18(1):252. doi: 10.1186/s12882-017-0669-4.

21.

Ofatumumab-associated acute pneumonitis: Not new but still the first case.

Bonanni A, Bertelli E, Panicucci C, D'Alessandro M, Moscatelli A, Lampugnani E, Sacco O, Magnano GM, Ravani P, Ghiggeri GM.

Pharmacol Res Perspect. 2016 Dec 26;5(1):e00267. doi: 10.1002/prp2.267. eCollection 2017 Feb.

22.

Are Female Applicants Rated Higher Than Males on the Multiple Mini-Interview? Findings From the University of Calgary.

Ross M, Walker I, Cooke L, Raman M, Ravani P, Coderre S, McLaughlin K.

Acad Med. 2017 Jun;92(6):841-846. doi: 10.1097/ACM.0000000000001466.

PMID:
28557950
23.

Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications.

Ravani P, Quinn R, Oliver M, Robinson B, Pisoni R, Pannu N, MacRae J, Manns B, Hemmelgarn B, James M, Tonelli M, Gillespie B.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):955-964. doi: 10.2215/CJN.12181116. Epub 2017 May 18.

24.

Clinical trials in minimal change disease.

Ravani P, Bertelli E, Gill S, Ghiggeri GM.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i7-i13. doi: 10.1093/ndt/gfw235. Review.

PMID:
28391333
25.
26.

Marginal structural models in clinical research: when and how to use them?

Williamson T, Ravani P.

Nephrol Dial Transplant. 2017 Apr 1;32(suppl_2):ii84-ii90. doi: 10.1093/ndt/gfw341.

PMID:
28201767
27.

Selection of peritoneal dialysis among older eligible patients with end-stage renal disease.

Wong B, Venturato L, Oliver MJ, Quinn RR, Ravani P, Holroyd-Leduc J.

Nephrol Dial Transplant. 2017 Feb 1;32(2):384-392. doi: 10.1093/ndt/gfw367.

PMID:
28186576
28.

The Effect of Predialysis Fistula Attempt on Risk of All-Cause and Access-Related Death.

Quinn RR, Oliver MJ, Devoe D, Poinen K, Kabani R, Kamar F, Mysore P, Lewin AM, Hiremath S, MacRae J, James MT, Miller L, Hemmelgarn BR, Moist LM, Garg AX, Chowdhury TT, Ravani P.

J Am Soc Nephrol. 2017 Feb;28(2):613-620. doi: 10.1681/ASN.2016020151. Epub 2016 Oct 6.

29.

Emergency Department Use among Patients with CKD: A Population-Based Analysis.

Ronksley PE, Tonelli M, Manns BJ, Weaver RG, Thomas CM, MacRae JM, Ravani P, Quinn RR, James MT, Lewanczuk R, Hemmelgarn BR.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):304-314. doi: 10.2215/CJN.06280616. Epub 2017 Jan 24.

30.

Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation.

Jun M, James MT, Ma Z, Zhang J, Tonelli M, McAlister FA, Manns BJ, Ravani P, Quinn RR, Wiebe N, Perkovic V, Wilton SB, Winkelmayer WC, Hemmelgarn BR; Alberta Kidney Disease Network.

Am J Kidney Dis. 2017 Jun;69(6):734-743. doi: 10.1053/j.ajkd.2016.10.018. Epub 2016 Dec 18.

PMID:
27998624
31.

ACCESS HD pilot: A randomised feasibility trial Comparing Catheters with fistulas in Elderly patientS Starting haemodialysis.

Quinn R, Ravani P; ACCESS HD Investigators.

BMJ Open. 2016 Nov 24;6(11):e013081. doi: 10.1136/bmjopen-2016-013081.

32.

Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertension.

Rymkiewicz P, Ravani P, Hemmelgarn BR, McAlister FA, Southern DA, Walker R, Chen G, Quan H.

BMC Health Serv Res. 2016 Nov 22;16(1):671.

33.

Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.

Ronksley PE, Hemmelgarn BR, Manns BJ, Wick J, James MT, Ravani P, Quinn RR, Scott-Douglas N, Lewanczuk R, Tonelli M.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2022-2031. Epub 2016 Oct 6.

34.

Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study.

Moroni G, Doria A, Giglio E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, de Liso F, Matinato C, Grossi C, Gatto M, Castellana P, Limardo M, Meroni PL, Messa P, Ravani P, Mosca M.

J Autoimmun. 2016 Nov;74:6-12. doi: 10.1016/j.jaut.2016.07.010. Epub 2016 Aug 2.

PMID:
27496151
35.

Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study.

Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, Gatto M, de Liso F, Grossi C, Meroni PL, Cabiddu G, Messa P, Ravani P, Mosca M.

J Autoimmun. 2016 Nov;74:194-200. doi: 10.1016/j.jaut.2016.06.012. Epub 2016 Jun 30.

PMID:
27373903
36.

Atrial fibrillation and chronic kidney disease: struggling through thick and thin.

Gill S, Jun M, Ravani P.

Nephrol Dial Transplant. 2017 Jul 1;32(7):1079-1084. doi: 10.1093/ndt/gfw378. Review.

PMID:
27742825
37.

Extracellular fluid management and hypertension in urban dwelling versus rural dwelling hemodialysis patients.

Tonelli M, Lloyd A, Pannu N, Klarenbach S, Ravani P, Jindal K, MacRae J, Unsworth L, Manns B, Hemmelgarn B.

J Nephrol. 2018 Feb;31(1):103-110. doi: 10.1007/s40620-016-0337-y. Epub 2016 Aug 23.

PMID:
27553110
38.

Incidence of melanoma in organ transplant recipients in Alberta, Canada.

Tran M, Sander M, Ravani P, Mydlarski PR.

Clin Transplant. 2016 Oct;30(10):1271-1275. doi: 10.1111/ctr.12818. Epub 2016 Sep 23.

PMID:
27448204
39.

Willingness to participate in a randomized trial comparing catheters to fistulas for vascular access in incident hemodialysis patients: an international survey of nephrologists.

Poinen K, Oliver MJ, Ravani P, Van der Veer SN, Jager KJ, Van Biesen W, Polkinghorne KR, Rosenfeld A, Lewin AM, Dulai M, Quinn RR.

Can J Kidney Health Dis. 2016 Jul 13;3:33. doi: 10.1186/s40697-016-0125-6. eCollection 2016.

40.

Ofatumumab-associated acute respiratory manifestations: clinical characteristics and treatment.

Bonanni A, Bertelli E, Moscatelli A, Lampugnani E, Bodria M, Ravani P, Ghiggeri GM.

Br J Clin Pharmacol. 2016 Oct;82(4):1146-8. doi: 10.1111/bcp.13029. Epub 2016 Jun 28. No abstract available.

41.

Citrate vs. acetate dialysate on intradialytic heparin dose: A double blind randomized crossover study.

Leung KC, Tai DJ, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM.

Hemodial Int. 2016 Oct;20(4):537-547. doi: 10.1111/hdi.12433. Epub 2016 Jun 20.

PMID:
27325599
42.

Patient Education and Peritoneal Dialysis Modality Selection: A Systematic Review and Meta-analysis.

Devoe DJ, Wong B, James MT, Ravani P, Oliver MJ, Barnieh L, Roberts DJ, Pauly R, Manns BJ, Kappel J, Quinn RR.

Am J Kidney Dis. 2016 Sep;68(3):422-33. doi: 10.1053/j.ajkd.2016.02.053. Epub 2016 Apr 26. Review.

PMID:
27125246
43.

The attributes of an effective teacher differ between the classroom and the clinical setting.

Haws J, Rannelli L, Schaefer JP, Zarnke K, Coderre S, Ravani P, McLaughlin K.

Adv Health Sci Educ Theory Pract. 2016 Oct;21(4):833-40. doi: 10.1007/s10459-016-9669-6. Epub 2016 Feb 18.

PMID:
26891679
44.

Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GF.

Am J Kidney Dis. 2016 Mar;67(3):446-60. doi: 10.1053/j.ajkd.2015.11.013. Epub 2016 Jan 6.

PMID:
26776537
45.

Pre-emptive correction for haemodialysis arteriovenous access stenosis.

Ravani P, Quinn RR, Oliver MJ, Karsanji DJ, James MT, MacRae JM, Palmer SC, Strippoli GF.

Cochrane Database Syst Rev. 2016 Jan 7;(1):CD010709. doi: 10.1002/14651858.CD010709.pub2. Review.

PMID:
26741512
46.

Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry.

Pippias M, Stel VS, Aresté-Fosalba N, Couchoud C, Fernandez-Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Pálsson R, Ravani P, Segelmark M, Traynor JP, Reisæter AV, Caskey FJ, Jager KJ.

Transplantation. 2016 Sep;100(9):1955-62. doi: 10.1097/TP.0000000000000962.

PMID:
26588008
47.

Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children.

Ravani P, Bonanni A, Rossi R, Caridi G, Ghiggeri GM.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):710-20. doi: 10.2215/CJN.08500815. Epub 2015 Nov 19. Review.

48.

A Pilot Study of IL2 in Drug-Resistant Idiopathic Nephrotic Syndrome.

Bonanni A, Bertelli R, Rossi R, Bruschi M, Di Donato A, Ravani P, Ghiggeri GM.

PLoS One. 2015 Sep 28;10(9):e0138343. doi: 10.1371/journal.pone.0138343. eCollection 2015.

49.

Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period.

van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remón C, Metcalfe W, Miguel A, Kramar R, Aasarød K, Abu Hanna A, Krediet RT, Schön S, Ravani P, Caskey FJ, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M.

Nephrol Dial Transplant. 2016 Jan;31(1):120-8. doi: 10.1093/ndt/gfv295. Epub 2015 Aug 26.

PMID:
26311215
50.

The effect of citrate dialysate on intradialytic heparin dose in haemodialysis patients: study design of a randomised controlled trial.

Tai DJ, Leung K, Ravani P, Quinn RR, Scott-Douglas N, MacRae JM; Alberta Kidney Disease Network.

BMC Nephrol. 2015 Aug 25;16:147. doi: 10.1186/s12882-015-0144-z.

Supplemental Content

Loading ...
Support Center